Benefits
Sarcopenia 12-week RCT protocol (PMC9524911 Kyung Hee)
PMC9524911 (Park 2022, Medicine 101:e30773) — Kyung Hee University Korean Medicine Hospital randomized double-blind placebo-controlled clinical trial protocol for SARCOPENIA. 104 adults with reduced muscle strength randomized 1:1 to C. lanceolata water extract (750 mg) vs crystalline cellulose placebo × 12 weeks. FIRST clinical trial in adults with reduced muscle strength.
Cognitive enhancement + AchE inhibition (PMC4083609)
PMC4083609 — fermented C. lanceolata (300, 500, 800 mg/kg) ameliorated SCOPOLAMINE-induced learning + memory impairment in mice (Morris water maze + passive avoidance tests). Inhibited acetylcholinesterase activity. Increased BDNF + CREB expression in brain. Mechanism: cholinergic + neurotrophic — Alzheimer's potential.
Anti-obesity diet-induced C57BL/6 mice (PMC4245555)
PMC4245555 (Lee 2014, Nutrients 6:4663) — Codonopsis lanceolata extract PREVENTS DIET-INDUCED OBESITY in C57BL/6 mice. HPLC-DAD characterization of phenolic compounds. Foundational anti-obesity mechanism evidence — extends adaptogen positioning to metabolic health applications.
Tangshenoside I + lobetyolin marker compounds
Hwang 2018 (Korean J Food Nutr 31:957-963) — quantitative analysis of TANGSHENOSIDE I + LOBETYOLIN from Korean Deodeok (C. lanceolata). Foundational marker compound identification supporting standardization. Tangshenoside I structurally similar to dangshenoside I in C. pilosula — shared genus heritage.
Bronchitis + asthma + cough TCM use
Korean + Chinese TCM use for BRONCHITIS, ASTHMA, COUGH, TUBERCULOSIS, DYSPEPSIA, PSYCHONEUROSIS. PMC11598484 (2024) review of recent indole alkaloid (Deodeokaloid) discovery + Helicobacter pylori + nitric oxide + antioxidant activity. Polyacetylenes + phenylpropanoids + alkaloids + triterpenoids + polysaccharides bioactive constituents.
Korean culinary food + medicine integration
Korean roots called DEODEOK (더덕) — used both fresh + cooked. Celery-root-like texture. Deodeok-gui (gochujang-marinated grilled) served as vegetarian main dish. Pan-fried jeon, pickled kimchi, fusion salads, deodeok-ju alcohol (medicinal home-brew). Also called SASAM (사삼; 沙蔘 'sand ginseng'). Distinguishing food-medicine integration.
HONEST distinguishing from C. pilosula (Dang Shen)
HONEST distinction: C. lanceolata (Korean Deodeok / Sasam / 'sand ginseng') is BOTANICALLY DIFFERENT from C. pilosula (Chinese Dang Shen / 'poor man's ginseng'). Different active compounds (lobetyolin vs codonopsine) + different traditional indications (lung-focused C. lanceolata vs spleen-focused C. pilosula). Same Codonopsis genus — varying constituents. Important sourcing clarity.
Mechanism of action
Acetylcholinesterase inhibition (cholinergic)
PMC4083609 — fermented C. lanceolata inhibits AchE in mice. Mechanism: cholinergic enhancement supporting cognitive function. Same target class as donepezil (Alzheimer's drug).
BDNF + CREB neurotrophic upregulation
PMC4083609 — increased BDNF + CREB expression in brain. Mechanism: neurotrophic factor + memory consolidation pathway activation supporting cognitive enhancement.
Lobetyolin polyacetylene bioactivity
Lobetyolin (polyacetylene) is a marker compound in C. lanceolata — distinct from C. pilosula codonopsine. Mechanism: polyacetylene-mediated bioactivity (anti-inflammatory + antioxidant).
Anti-obesity phenolic compound profile
Lee 2014 PMC4245555 — phenolic compounds (HPLC-DAD characterization) prevent diet-induced obesity in mice. Mechanism: phenolic anti-inflammatory + adipogenesis modulation.
Pulmonary anti-inflammatory (TCM 'lung-focused')
TCM use for bronchitis + asthma + cough + tuberculosis. Mechanism: pulmonary anti-inflammatory + expectorant — supports lung function via TCM 'sand ginseng' positioning.
Deodeokaloid + indole alkaloid antimicrobial
PMC11598484 (2024) — newly discovered DEODEOKALOID (indole alkaloid N-glycoside) shows H. pylori inhibition + nitric oxide + antioxidant activity. Mechanism: novel alkaloid bioactivity supporting GI + respiratory applications.
Clinical trials
Randomized double-blind placebo-controlled clinical trial protocol (Park 2022, Medicine 101:e30773). Kyung Hee University Korean Medicine Hospital at Gangdong (IRB approval July 15, 2021, MLB_DDE_H01). Korean Clinical Research Information Service registration December 3, 2021 (PRE20211203-003).
104 adults with reduced muscle strength (sarcopenia). 1:1 randomization to C. lanceolata water extract 750 mg tablet vs crystalline cellulose placebo. Once daily before breakfast × 12 weeks (84 days). Endpoints: skeletal muscle mass + muscle strength + performance function + safety.
FIRST CLINICAL TRIAL of C. lanceolata water extract in adults with reduced muscle strength. Foundational sarcopenia evidence — important muscle mass + function application extending traditional 'tonic' use to age-related muscle loss. Protocol publication — full results pending.
Animal study (Department of Medical Biomaterials Engineering + Microbiology + Immunology + Functional Food & Nutrition + Newtree Co.).
Mice with scopolamine-induced learning + memory impairment. Fermented C. lanceolata (300, 500, 800 mg/kg) administration. Morris water maze + passive avoidance tests. AchE activity + BDNF + CREB expression.
Fermented C. lanceolata (800 mg/kg) reduced scopolamine-induced memory impairment in BOTH Morris water maze + passive avoidance tests. INHIBITED AchE activity. Increased BDNF + CREB expression in brain. Foundational cognitive enhancement mechanism evidence — Alzheimer's research candidate. Fermentation enhances bioactivity vs unfermented.
Mouse study (Lee JS et al. 2014, Nutrients 6:4663). Kangwon National University + University of Maryland + Hurum Central Research Institute.
C57BL/6 mice with diet-induced obesity. C. lanceolata extract (CLE) administration. HPLC-DAD characterization of phenolic compounds.
C. lanceolata extract PREVENTS diet-induced obesity in C57BL/6 mice. Phenolic compound profile characterization supports anti-obesity mechanism evidence. Foundational metabolic health application extending adaptogen + tonic positioning.
About this ingredient
CODONOPSIS LANCEOLATA is KOREAN DEODEOK (더덕) / SASAM (사삼; 沙蔘 'sand ginseng') / KOREAN BONNET BELLFLOWER — Campanulaceae perennial herb. Distinct from C. pilosula (Chinese Dang Shen) — same Codonopsis genus but DIFFERENT BOTANICAL SPECIES + DIFFERENT ACTIVE COMPOUNDS + DIFFERENT TRADITIONAL INDICATIONS. Korean + Chinese TCM use for BRONCHITIS, ASTHMA, COUGH, TUBERCULOSIS, DYSPEPSIA, PSYCHONEUROSIS, anti-cancer. Lance-shaped leaves (epithet lanceolata). Active compounds: TANGSHENOSIDE I (structurally similar to dangshenoside I in C. pilosula — shared genus), LOBETYOLIN (polyacetylene marker), DEODEOKALOID (newly discovered indole alkaloid N-glycoside per PMC11598484 2024), POLYACETYLENES, PHENYLPROPANOIDS, TRITERPENOIDS, POLYSACCHARIDES, ALKALOIDS. PIVOTAL CLINICAL EVIDENCE: PMC9524911 (PARK 2022, Medicine 101:e30773) — Kyung Hee University Korean Medicine Hospital at Gangdong RCT protocol for SARCOPENIA. 104 adults with reduced muscle strength randomized 1:1 to 750 mg C. lanceolata water extract tablet vs crystalline cellulose placebo × 12 weeks. FIRST clinical trial in adults with reduced muscle strength. PMC4083609 — fermented C. lanceolata (300, 500, 800 mg/kg) ameliorated scopolamine-induced learning + memory impairment in mice; inhibited AchE; increased BDNF + CREB expression. PMC4245555 (LEE 2014, Nutrients 6:4663) — anti-obesity in C57BL/6 mice (HPLC-DAD characterized phenolic compounds). HWANG 2018 (Korean J Food Nutr 31:957-963) — quantitative analysis of tangshenoside I + lobetyolin marker compounds. PMC11598484 (2024) — Deodeokaloid discovery + H. pylori + NO + antioxidant activity. KOREAN CULINARY INTEGRATION: deodeok-gui (gochujang-marinated grilled) vegetarian main dish, jeon (pan-fried), kimchi, fusion salads, deodeok-ju alcohol.
MECHANISMS: ACETYLCHOLINESTERASE INHIBITION (PMC4083609 cholinergic — same target as donepezil); BDNF + CREB NEUROTROPHIC upregulation (memory consolidation); LOBETYOLIN polyacetylene bioactivity (distinct from C. pilosula codonopsine); ANTI-OBESITY phenolic compound profile (Lee 2014); PULMONARY ANTI-INFLAMMATORY (TCM 'lung-focused' bronchitis/asthma); DEODEOKALOID + INDOLE ALKALOID antimicrobial (H. pylori). EVIDENCE: 3/5 reflects: (1) PMC9524911 SARCOPENIA RCT protocol Kyung Hee (n=104, 12 weeks — first clinical trial in adults with reduced muscle strength), (2) PMC4083609 cognitive enhancement mouse mechanism (AchE inhibition + BDNF + CREB), (3) PMC4245555 anti-obesity C57BL/6 mouse evidence, (4) HWANG 2018 marker compound standardization (tangshenoside I + lobetyolin), (5) PMC11598484 (2024) Deodeokaloid discovery + H. pylori activity, (6) KOREAN CULINARY food + medicine integration (extensive dietary use record), (7) DISTINGUISHING from C. pilosula (different species + compounds + indications), (8) MULTI-SYSTEM applications (sarcopenia, cognitive, anti-obesity, pulmonary, antimicrobial), (9) HONEST FRAMING — most evidence preclinical (mice) + RCT protocol publication (results pending), (10) higher-evidence than typical TCM herb due to dedicated Korean Medicine Hospital research base. SAFETY: Excellent — extensive Korean culinary use record (deodeok food) + Korean clinical research base. Best positioned as: (a) SARCOPENIA + MUSCLE STRENGTH support in older adults (Kyung Hee Park 2022 RCT), (b) COGNITIVE ENHANCEMENT + memory support (PMC4083609 AchE + BDNF mechanism), (c) PULMONARY HEALTH adjunct — bronchitis + asthma + cough (TCM 'sand ginseng' tradition), (d) ANTI-OBESITY metabolic support (PMC4245555), (e) H. PYLORI antimicrobial research candidate (PMC11598484 Deodeokaloid), (f) KOREAN CULINARY INTEGRATION (deodeok-gui, jeon, kimchi, deodeok-ju), (g) DISTINGUISHING from C. pilosula — important sourcing clarity, (h) PREGNANCY: TCM record but limited Western data, (i) CHOLINERGIC MEDICATION: theoretical additive (donepezil interaction), (j) higher-evidence than typical TCM herb due to dedicated Korean Medicine Hospital research + culinary integration. Honest framing: Codonopsis lanceolata (Korean Deodeok / 'sand ginseng') has SOLID EMERGING EVIDENCE base — Kyung Hee University Park 2022 PMC9524911 SARCOPENIA RCT protocol (first clinical trial in reduced muscle strength adults) + PMC4083609 cognitive mouse mechanism + PMC4245555 anti-obesity mouse + PMC11598484 (2024) Deodeokaloid discovery support multi-system positioning. CRITICAL DISTINCTION from C. pilosula (Chinese Dang Shen): different botanical species + different active compounds (lobetyolin vs codonopsine) + different traditional indications (LUNG-FOCUSED C. lanceolata vs SPLEEN-FOCUSED C. pilosula). Same Codonopsis genus — varying constituents. Sourcing clarity important. Korean culinary integration (deodeok food) supports excellent safety profile. Most clinical evidence in MOUSE MODELS + RCT protocol publication (Park 2022 results pending) — direct human RCT evidence still emerging. Reasonable adaptogen for sarcopenia + cognitive + pulmonary + anti-obesity applications based on Korean Medicine Hospital research + extensive culinary safety record — particularly compelling for those wanting Korean-heritage adaptogen distinct from Chinese Dang Shen. Position as KOREAN CULINARY-MEDICAL HERITAGE + EMERGING CLINICAL EVIDENCE.